Medical Journal of Islamic World Academy of Sciences. 2013; 21 (2): 77-80
in English
| IMEMR
| ID: emr-143226
ABSTRACT
To study the effect of intravitreal avastin on systemic blood pressure in controlled hypertensive patients. This is a retrospective study to evaluate blood pressure changes in hypertensive patients with ischemic ocular pathologies after a 0.05 ml [1.25 mg] intravitreal avastin injection. It included 40 patients with retinal vascular diseases; their blood pressure was measured before the treatment [IVA] as a baseline, and then it was measured after 1 day, 1 week, 4 weeks, and then monthly for at least 3 months. All patients were given the same concentration of avastin intravitreally [0.05 ml], and their blood pressure was measured in supine position using the digital sphygmomanometer. The elevation in blood pressure was noted in 90% of the patients from the baseline on the first day postinjection. No significant changes were observed on blood pressure in 1 week, 4 weeks, and other readings postinjection. Treating ocular vascular diseases with intravitreal avastin is safe in controlled hypertensive patients
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Retinal Diseases
/
Retinal Vessels
/
Blood Pressure
/
Retrospective Studies
/
Sphygmomanometers
/
Intravitreal Injections
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Med. J. Islamic World Acad. Sci.
Year:
2013
Similar
MEDLINE
...
LILACS
LIS